 Herbert T. Abelson
Concepts (341)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Undergraduate | 2 | 2014 | 129 | 0.980 |
Why?
| | Methotrexate | 19 | 1985 | 242 | 0.650 |
Why?
| | Life Change Events | 1 | 2013 | 37 | 0.590 |
Why?
| | Physical Examination | 1 | 2014 | 137 | 0.590 |
Why?
| | Job Satisfaction | 1 | 2013 | 58 | 0.570 |
Why?
| | Clinical Clerkship | 1 | 2014 | 98 | 0.570 |
Why?
| | Training Support | 2 | 2012 | 19 | 0.560 |
Why?
| | Science | 1 | 2012 | 33 | 0.530 |
Why?
| | Diffusion of Innovation | 1 | 2012 | 68 | 0.530 |
Why?
| | Research Support as Topic | 1 | 2012 | 76 | 0.530 |
Why?
| | Financing, Personal | 1 | 2012 | 21 | 0.520 |
Why?
| | Translational Medical Research | 1 | 2012 | 107 | 0.500 |
Why?
| | Curriculum | 1 | 2014 | 386 | 0.470 |
Why?
| | Physician's Role | 1 | 2012 | 181 | 0.460 |
Why?
| | Students, Medical | 1 | 2013 | 281 | 0.440 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2001 | 12 | 0.410 |
Why?
| | Professional Practice | 1 | 2008 | 46 | 0.390 |
Why?
| | Air Pollution | 1 | 2005 | 26 | 0.330 |
Why?
| | Environmental Monitoring | 1 | 2005 | 64 | 0.330 |
Why?
| | Air Pollutants | 1 | 2005 | 34 | 0.330 |
Why?
| | beta-Thalassemia | 1 | 2004 | 5 | 0.320 |
Why?
| | Hemoglobin C Disease | 1 | 2004 | 5 | 0.320 |
Why?
| | Pediatrics | 3 | 2001 | 313 | 0.310 |
Why?
| | Central Nervous System Diseases | 1 | 2003 | 46 | 0.300 |
Why?
| | Erythrocytes | 1 | 2004 | 251 | 0.290 |
Why?
| | Tetrahydrofolate Dehydrogenase | 8 | 1985 | 33 | 0.290 |
Why?
| | Environmental Exposure | 1 | 2005 | 244 | 0.280 |
Why?
| | Osteosarcoma | 6 | 1985 | 151 | 0.270 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 554 | 0.260 |
Why?
| | Leukemia | 1 | 2003 | 285 | 0.260 |
Why?
| | Employment | 1 | 2001 | 45 | 0.250 |
Why?
| | Career Choice | 2 | 2001 | 119 | 0.250 |
Why?
| | Hemoglobins | 1 | 2001 | 159 | 0.240 |
Why?
| | Forecasting | 2 | 2008 | 289 | 0.190 |
Why?
| | Blood Cell Count | 2 | 1996 | 76 | 0.190 |
Why?
| | Humans | 38 | 2014 | 72293 | 0.180 |
Why?
| | Bone Neoplasms | 5 | 1985 | 303 | 0.170 |
Why?
| | Education, Medical | 2 | 2013 | 194 | 0.170 |
Why?
| | Leucovorin | 6 | 1985 | 222 | 0.170 |
Why?
| | Apnea | 1 | 1995 | 24 | 0.160 |
Why?
| | Child Behavior | 1 | 1995 | 43 | 0.160 |
Why?
| | Leukemia L1210 | 3 | 1980 | 11 | 0.130 |
Why?
| | Thymidine | 2 | 1983 | 63 | 0.130 |
Why?
| | Brain | 6 | 1978 | 1933 | 0.130 |
Why?
| | Lymphoma | 3 | 1981 | 263 | 0.120 |
Why?
| | Kinetics | 12 | 1983 | 1582 | 0.120 |
Why?
| | United States | 6 | 2005 | 5310 | 0.120 |
Why?
| | Biopterin | 3 | 1978 | 10 | 0.120 |
Why?
| | Physicians, Women | 1 | 1990 | 31 | 0.110 |
Why?
| | HeLa Cells | 6 | 1974 | 486 | 0.110 |
Why?
| | Child | 8 | 2004 | 5795 | 0.100 |
Why?
| | Pteridines | 2 | 1978 | 6 | 0.100 |
Why?
| | Practice Management, Medical | 1 | 2008 | 20 | 0.100 |
Why?
| | Antineoplastic Agents | 4 | 1981 | 2190 | 0.100 |
Why?
| | RNA, Neoplasm | 4 | 1977 | 97 | 0.090 |
Why?
| | RNA | 6 | 1979 | 477 | 0.090 |
Why?
| | Folic Acid Antagonists | 3 | 1980 | 20 | 0.090 |
Why?
| | United States Environmental Protection Agency | 1 | 2005 | 5 | 0.090 |
Why?
| | Absenteeism | 1 | 2005 | 10 | 0.080 |
Why?
| | Particle Size | 1 | 2005 | 147 | 0.080 |
Why?
| | Brain Neoplasms | 3 | 1981 | 728 | 0.080 |
Why?
| | Hemoglobin A2 | 1 | 2004 | 2 | 0.080 |
Why?
| | Blood Protein Electrophoresis | 1 | 2004 | 16 | 0.080 |
Why?
| | Pneumonia | 1 | 2005 | 135 | 0.080 |
Why?
| | Homozygote | 1 | 2004 | 194 | 0.080 |
Why?
| | Abelson murine leukemia virus | 1 | 2003 | 3 | 0.080 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2004 | 313 | 0.080 |
Why?
| | Formates | 1 | 1983 | 8 | 0.070 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 1983 | 35 | 0.070 |
Why?
| | Mice | 13 | 2003 | 10276 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 183 | 0.070 |
Why?
| | Carboxypeptidases | 2 | 1981 | 35 | 0.070 |
Why?
| | Infant | 4 | 2000 | 2744 | 0.070 |
Why?
| | Health Care Coalitions | 1 | 2002 | 8 | 0.070 |
Why?
| | Male | 12 | 2012 | 37354 | 0.070 |
Why?
| | Female | 11 | 2012 | 39738 | 0.070 |
Why?
| | Total Quality Management | 1 | 2002 | 35 | 0.060 |
Why?
| | Blood Platelets | 2 | 1979 | 132 | 0.060 |
Why?
| | Directories as Topic | 1 | 2001 | 1 | 0.060 |
Why?
| | Animals | 20 | 2003 | 25007 | 0.060 |
Why?
| | Safety Management | 1 | 2002 | 58 | 0.060 |
Why?
| | Thalassemia | 1 | 2001 | 16 | 0.060 |
Why?
| | Diagnosis, Differential | 2 | 2004 | 1513 | 0.060 |
Why?
| | Leadership | 1 | 2002 | 84 | 0.060 |
Why?
| | Thymus Gland | 3 | 1971 | 214 | 0.060 |
Why?
| | Pyrimethamine | 1 | 1980 | 20 | 0.060 |
Why?
| | Thymine Nucleotides | 1 | 1980 | 6 | 0.060 |
Why?
| | Deoxyuracil Nucleotides | 1 | 1980 | 5 | 0.060 |
Why?
| | Medical Errors | 1 | 2002 | 111 | 0.060 |
Why?
| | Extremities | 2 | 1985 | 172 | 0.060 |
Why?
| | Iron | 1 | 2001 | 150 | 0.060 |
Why?
| | Cell Line | 9 | 1985 | 2517 | 0.060 |
Why?
| | Leukemia, Experimental | 3 | 1985 | 16 | 0.050 |
Why?
| | Dihydropteridine Reductase | 1 | 1979 | 1 | 0.050 |
Why?
| | RNA, Messenger | 6 | 1977 | 1916 | 0.050 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 1979 | 10 | 0.050 |
Why?
| | Interphase | 1 | 1978 | 37 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1983 | 408 | 0.050 |
Why?
| | Rosette Formation | 1 | 1978 | 34 | 0.050 |
Why?
| | Leukemia, Lymphoid | 4 | 1982 | 72 | 0.050 |
Why?
| | Ascitic Fluid | 1 | 1978 | 38 | 0.050 |
Why?
| | Drug Therapy, Combination | 4 | 1983 | 895 | 0.050 |
Why?
| | Asthma | 1 | 2005 | 743 | 0.050 |
Why?
| | Internet | 1 | 2001 | 283 | 0.050 |
Why?
| | RNA, Ribosomal | 5 | 1977 | 61 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2003 | 2044 | 0.050 |
Why?
| | Drug Resistance | 4 | 1984 | 254 | 0.050 |
Why?
| | African Continental Ancestry Group | 1 | 2001 | 521 | 0.050 |
Why?
| | Amygdalin | 1 | 1977 | 3 | 0.050 |
Why?
| | Neutrophils | 1 | 1978 | 248 | 0.050 |
Why?
| | Nitriles | 1 | 1977 | 80 | 0.050 |
Why?
| | Reticulocyte Count | 1 | 1996 | 3 | 0.050 |
Why?
| | Anemia, Macrocytic | 1 | 1996 | 5 | 0.050 |
Why?
| | Thrombocytosis | 1 | 1996 | 9 | 0.050 |
Why?
| | Anemia, Neonatal | 1 | 1996 | 7 | 0.040 |
Why?
| | Rabbits | 4 | 1978 | 689 | 0.040 |
Why?
| | Platelet Count | 1 | 1996 | 78 | 0.040 |
Why?
| | Time Factors | 9 | 1983 | 5095 | 0.040 |
Why?
| | Kidney | 4 | 1971 | 1156 | 0.040 |
Why?
| | Cell Cycle | 1 | 1978 | 499 | 0.040 |
Why?
| | Melanoma | 1 | 1980 | 400 | 0.040 |
Why?
| | Doxorubicin | 5 | 1985 | 284 | 0.040 |
Why?
| | Cell Nucleus | 5 | 1975 | 560 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 1996 | 149 | 0.040 |
Why?
| | Skin Neoplasms | 1 | 1980 | 483 | 0.040 |
Why?
| | Tritium | 6 | 1975 | 139 | 0.040 |
Why?
| | Child, Preschool | 4 | 2000 | 3389 | 0.040 |
Why?
| | Mechlorethamine | 1 | 1974 | 11 | 0.040 |
Why?
| | Nitrosourea Compounds | 1 | 1974 | 9 | 0.040 |
Why?
| | Infant, Newborn | 3 | 1996 | 2092 | 0.040 |
Why?
| | DNA | 3 | 1984 | 1260 | 0.040 |
Why?
| | Alkylating Agents | 1 | 1974 | 31 | 0.040 |
Why?
| | Carmustine | 1 | 1974 | 72 | 0.040 |
Why?
| | Amputation | 3 | 1985 | 57 | 0.040 |
Why?
| | Cell Nucleolus | 4 | 1974 | 21 | 0.040 |
Why?
| | Ribonucleosides | 1 | 1973 | 27 | 0.040 |
Why?
| | Respiration | 1 | 1995 | 227 | 0.040 |
Why?
| | DNA, Neoplasm | 2 | 1977 | 273 | 0.040 |
Why?
| | Internship and Residency | 1 | 2001 | 780 | 0.030 |
Why?
| | Cell Division | 4 | 1979 | 738 | 0.030 |
Why?
| | Cytidine | 1 | 1972 | 15 | 0.030 |
Why?
| | Neoplasms | 2 | 1985 | 2260 | 0.030 |
Why?
| | Anemia, Sickle Cell | 1 | 1974 | 109 | 0.030 |
Why?
| | Anesthesia | 1 | 1974 | 137 | 0.030 |
Why?
| | Camptothecin | 2 | 1973 | 193 | 0.030 |
Why?
| | Alkaloids | 1 | 1972 | 46 | 0.030 |
Why?
| | Microscopy, Electron | 5 | 1971 | 513 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 3 | 1977 | 395 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 3 | 1983 | 1990 | 0.030 |
Why?
| | Vincristine | 2 | 1981 | 109 | 0.030 |
Why?
| | Gammaretrovirus | 1 | 1971 | 4 | 0.030 |
Why?
| | Lymphoma, Non-Hodgkin | 2 | 1970 | 244 | 0.030 |
Why?
| | Antigens | 2 | 1970 | 251 | 0.030 |
Why?
| | Anemia, Hemolytic | 1 | 1990 | 17 | 0.030 |
Why?
| | Moloney murine leukemia virus | 1 | 1970 | 6 | 0.030 |
Why?
| | Leukemia Virus, Murine | 1 | 1970 | 17 | 0.030 |
Why?
| | Prednisolone | 1 | 1970 | 43 | 0.030 |
Why?
| | Cell Biology | 1 | 1970 | 13 | 0.030 |
Why?
| | Membranes | 1 | 1970 | 32 | 0.030 |
Why?
| | Uridine | 4 | 1974 | 48 | 0.030 |
Why?
| | Lung Neoplasms | 4 | 1983 | 1873 | 0.030 |
Why?
| | Medulloblastoma | 2 | 1981 | 32 | 0.030 |
Why?
| | Cytoplasm | 5 | 1977 | 278 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 1990 | 107 | 0.030 |
Why?
| | Culture Techniques | 1 | 1969 | 100 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 3 | 1973 | 115 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 1971 | 280 | 0.030 |
Why?
| | Adolescent | 5 | 2000 | 8076 | 0.030 |
Why?
| | Sarcoma, Experimental | 2 | 1983 | 56 | 0.030 |
Why?
| | Diabetes Insipidus | 1 | 1968 | 19 | 0.030 |
Why?
| | Social Support | 1 | 1990 | 169 | 0.030 |
Why?
| | Liver | 4 | 1985 | 1165 | 0.020 |
Why?
| | Faculty, Medical | 1 | 1990 | 147 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 1990 | 308 | 0.020 |
Why?
| | Cells, Cultured | 5 | 1985 | 2829 | 0.020 |
Why?
| | Antibodies | 1 | 1969 | 351 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 1975 | 302 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 1990 | 390 | 0.020 |
Why?
| | Hypoxanthines | 2 | 1983 | 11 | 0.020 |
Why?
| | Molecular Weight | 2 | 1979 | 367 | 0.020 |
Why?
| | Hypoxanthine | 1 | 1983 | 3 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 1983 | 31 | 0.020 |
Why?
| | Gene Amplification | 1 | 1984 | 157 | 0.020 |
Why?
| | Inulin | 1 | 1983 | 15 | 0.020 |
Why?
| | Mitochondria | 3 | 1973 | 485 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1983 | 323 | 0.020 |
Why?
| | Dactinomycin | 2 | 1972 | 39 | 0.020 |
Why?
| | Tissue Distribution | 2 | 1985 | 279 | 0.020 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 1982 | 10 | 0.020 |
Why?
| | Organizational Culture | 1 | 2002 | 30 | 0.020 |
Why?
| | DNA Nucleotidyltransferases | 1 | 1982 | 29 | 0.020 |
Why?
| | Creatinine | 1 | 1983 | 321 | 0.020 |
Why?
| | Depression, Chemical | 2 | 1972 | 32 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 1983 | 337 | 0.020 |
Why?
| | Injections, Intraventricular | 1 | 1981 | 20 | 0.020 |
Why?
| | Meninges | 2 | 1971 | 13 | 0.020 |
Why?
| | Ribosomes | 2 | 1973 | 102 | 0.020 |
Why?
| | Probability | 1 | 1981 | 337 | 0.010 |
Why?
| | Chromatography, Thin Layer | 1 | 1980 | 39 | 0.010 |
Why?
| | Hematocrit | 2 | 1990 | 73 | 0.010 |
Why?
| | Angiography | 1 | 1981 | 184 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1982 | 1023 | 0.010 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 1979 | 24 | 0.010 |
Why?
| | Thymidine Kinase | 1 | 1979 | 28 | 0.010 |
Why?
| | Lymphocytes | 1 | 1982 | 447 | 0.010 |
Why?
| | Blood | 1 | 1979 | 73 | 0.010 |
Why?
| | Culture Media | 1 | 1979 | 177 | 0.010 |
Why?
| | Kidney Glomerulus | 2 | 1970 | 112 | 0.010 |
Why?
| | Biological Transport | 1 | 1979 | 403 | 0.010 |
Why?
| | RNA, Transfer | 2 | 1977 | 133 | 0.010 |
Why?
| | Phenylalanine Hydroxylase | 1 | 1978 | 2 | 0.010 |
Why?
| | Kidney Tubules | 2 | 1970 | 98 | 0.010 |
Why?
| | Neoplasm Metastasis | 2 | 1985 | 960 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 1981 | 921 | 0.010 |
Why?
| | Species Specificity | 2 | 1970 | 656 | 0.010 |
Why?
| | Bronchial Neoplasms | 1 | 1978 | 9 | 0.010 |
Why?
| | Cell Survival | 2 | 1978 | 981 | 0.010 |
Why?
| | Clone Cells | 1 | 1978 | 297 | 0.010 |
Why?
| | Drug Interactions | 1 | 1978 | 261 | 0.010 |
Why?
| | Tetrahydrofolates | 1 | 1977 | 13 | 0.010 |
Why?
| | Meningeal Neoplasms | 1 | 1978 | 47 | 0.010 |
Why?
| | Choroid Plexus | 1 | 1977 | 13 | 0.010 |
Why?
| | Methods | 2 | 1985 | 160 | 0.010 |
Why?
| | Meningioma | 1 | 1978 | 45 | 0.010 |
Why?
| | Brain Chemistry | 1 | 1978 | 122 | 0.010 |
Why?
| | Astrocytoma | 1 | 1978 | 74 | 0.010 |
Why?
| | Folic Acid | 1 | 1977 | 45 | 0.010 |
Why?
| | Radiation Injuries | 1 | 1978 | 157 | 0.010 |
Why?
| | Adenosine | 3 | 1975 | 196 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1978 | 356 | 0.010 |
Why?
| | Organ Specificity | 1 | 1977 | 239 | 0.010 |
Why?
| | Ribonucleases | 2 | 1974 | 87 | 0.010 |
Why?
| | Fruit | 1 | 1977 | 68 | 0.010 |
Why?
| | Fetus | 1 | 1977 | 206 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 1985 | 2038 | 0.010 |
Why?
| | Carbon Isotopes | 2 | 1973 | 74 | 0.010 |
Why?
| | Deoxyadenosines | 2 | 1975 | 21 | 0.010 |
Why?
| | Breast Neoplasms | 2 | 1981 | 2496 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1977 | 530 | 0.010 |
Why?
| | Glioblastoma | 1 | 1978 | 226 | 0.010 |
Why?
| | Bone Marrow | 2 | 1982 | 405 | 0.010 |
Why?
| | Glioma | 1 | 1978 | 284 | 0.010 |
Why?
| | Fibroblasts | 2 | 1977 | 702 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1974 | 81 | 0.010 |
Why?
| | Adult | 3 | 1983 | 23156 | 0.010 |
Why?
| | Reticulocytes | 2 | 1990 | 23 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 1974 | 183 | 0.010 |
Why?
| | Formamides | 1 | 1973 | 2 | 0.010 |
Why?
| | Alkalies | 1 | 1973 | 7 | 0.010 |
Why?
| | Isotope Labeling | 1 | 1973 | 54 | 0.010 |
Why?
| | Nucleic Acid Denaturation | 1 | 1973 | 38 | 0.010 |
Why?
| | Centrifugation, Zonal | 1 | 1972 | 10 | 0.010 |
Why?
| | Ethidium | 1 | 1972 | 14 | 0.010 |
Why?
| | Sucrose | 1 | 1973 | 59 | 0.010 |
Why?
| | DNA, Single-Stranded | 1 | 1973 | 84 | 0.010 |
Why?
| | Electrophoresis | 1 | 1972 | 59 | 0.010 |
Why?
| | Acrylamides | 1 | 1972 | 26 | 0.010 |
Why?
| | Aging | 1 | 1977 | 641 | 0.010 |
Why?
| | Pancreas | 1 | 1974 | 244 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1972 | 189 | 0.010 |
Why?
| | Pyrazoles | 1 | 1973 | 142 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1973 | 533 | 0.010 |
Why?
| | Adrenal Glands | 1 | 1971 | 84 | 0.010 |
Why?
| | Lymphatic System | 1 | 1971 | 46 | 0.010 |
Why?
| | Leukemoid Reaction | 1 | 1970 | 5 | 0.010 |
Why?
| | DNA Repair | 1 | 1973 | 329 | 0.010 |
Why?
| | Pyrimidines | 1 | 1973 | 320 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1985 | 1553 | 0.010 |
Why?
| | Urography | 1 | 1970 | 44 | 0.010 |
Why?
| | Ammonia | 1 | 1970 | 39 | 0.010 |
Why?
| | Hypertrophy | 1 | 1970 | 65 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 2 | 1984 | 252 | 0.010 |
Why?
| | Hemoglobinometry | 1 | 1969 | 8 | 0.010 |
Why?
| | Haplorhini | 1 | 1970 | 104 | 0.010 |
Why?
| | Polycythemia | 1 | 1969 | 8 | 0.010 |
Why?
| | Fetal Hemoglobin | 1 | 1969 | 8 | 0.010 |
Why?
| | Erythrocyte Count | 1 | 1969 | 20 | 0.010 |
Why?
| | Organ Size | 1 | 1971 | 347 | 0.010 |
Why?
| | Cricetinae | 2 | 1984 | 572 | 0.010 |
Why?
| | Twins | 1 | 1970 | 70 | 0.010 |
Why?
| | Growth Disorders | 1 | 1970 | 59 | 0.010 |
Why?
| | Bone Diseases | 1 | 1970 | 51 | 0.010 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1970 | 112 | 0.010 |
Why?
| | Spleen | 1 | 1971 | 493 | 0.010 |
Why?
| | Adenocarcinoma | 1 | 1978 | 1174 | 0.010 |
Why?
| | Antigen-Antibody Reactions | 1 | 1969 | 35 | 0.010 |
Why?
| | Body Weight | 1 | 1971 | 437 | 0.010 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 1969 | 10 | 0.010 |
Why?
| | Birth Weight | 1 | 1969 | 132 | 0.010 |
Why?
| | Peroxidases | 1 | 1969 | 37 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1969 | 136 | 0.010 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 1969 | 52 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1969 | 104 | 0.010 |
Why?
| | Leukemia, Myeloid | 1 | 1970 | 242 | 0.010 |
Why?
| | Microscopy | 1 | 1969 | 76 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1969 | 332 | 0.010 |
Why?
| | Aged | 2 | 1982 | 16344 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1971 | 490 | 0.010 |
Why?
| | Binding Sites | 1 | 1969 | 1084 | 0.010 |
Why?
| | Random Allocation | 1 | 1985 | 335 | 0.010 |
Why?
| | NADP | 1 | 1985 | 55 | 0.010 |
Why?
| | Prostheses and Implants | 1 | 1985 | 119 | 0.010 |
Why?
| | Middle Aged | 2 | 1982 | 22879 | 0.000 |
Why?
| | Demecolcine | 1 | 1984 | 1 | 0.000 |
Why?
| | Chickens | 1 | 1985 | 221 | 0.000 |
Why?
| | Polynucleotides | 2 | 1975 | 17 | 0.000 |
Why?
| | Cricetulus | 1 | 1984 | 124 | 0.000 |
Why?
| | Cattle | 1 | 1985 | 372 | 0.000 |
Why?
| | Cell Fractionation | 2 | 1975 | 73 | 0.000 |
Why?
| | Adenine | 2 | 1975 | 53 | 0.000 |
Why?
| | Pregnancy | 1 | 1970 | 2466 | 0.000 |
Why?
| | Ovary | 1 | 1984 | 222 | 0.000 |
Why?
| | Rats | 1 | 1970 | 4151 | 0.000 |
Why?
| | Blood Proteins | 1 | 1982 | 146 | 0.000 |
Why?
| | Mice, Inbred AKR | 1 | 1982 | 14 | 0.000 |
Why?
| | Chromatography, Ion Exchange | 1 | 1982 | 39 | 0.000 |
Why?
| | Mice, Inbred DBA | 1 | 1982 | 190 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1985 | 1078 | 0.000 |
Why?
| | Macaca mulatta | 1 | 1982 | 412 | 0.000 |
Why?
| | Biological Transport, Active | 1 | 1980 | 104 | 0.000 |
Why?
| | Base Sequence | 1 | 1984 | 2367 | 0.000 |
Why?
| | Protein Binding | 1 | 1982 | 1416 | 0.000 |
Why?
| | Lung | 1 | 1984 | 972 | 0.000 |
Why?
| | Prognosis | 1 | 1985 | 3279 | 0.000 |
Why?
| | Polyomavirus | 1 | 1977 | 15 | 0.000 |
Why?
| | Poly A | 1 | 1977 | 23 | 0.000 |
Why?
| | Simian virus 40 | 1 | 1977 | 34 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1983 | 3431 | 0.000 |
Why?
| | Phosphorus Radioisotopes | 1 | 1975 | 19 | 0.000 |
Why?
| | Poly U | 1 | 1975 | 6 | 0.000 |
Why?
| | T-Lymphocytes | 1 | 1982 | 1173 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1982 | 2916 | 0.000 |
Why?
| | Puromycin | 1 | 1973 | 10 | 0.000 |
Why?
| | Deoxyribonucleases | 1 | 1973 | 28 | 0.000 |
Why?
| | Priapism | 1 | 1969 | 12 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1969 | 39 | 0.000 |
Why?
| | Hypoglycemia | 1 | 1969 | 100 | 0.000 |
Why?
| | Gestational Age | 1 | 1969 | 290 | 0.000 |
Why?
| | Respiratory Insufficiency | 1 | 1969 | 122 | 0.000 |
Why?
| | Infant, Premature | 1 | 1969 | 246 | 0.000 |
Why?
| | Sex Factors | 1 | 1969 | 1002 | 0.000 |
Why?
|
|
Abelson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|